2009
DOI: 10.1016/j.bbrc.2008.12.160
|View full text |Cite
|
Sign up to set email alerts
|

Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
53
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 68 publications
(55 citation statements)
references
References 21 publications
2
53
0
Order By: Relevance
“…1,3,39,40 However, current knowledge is still unsystematic and restricted to particular aspects of nanoparticles' capability to induce toxic and pathological processes or to alter structure and function in different cell types. 41À43 Nevertheless, among nanoparticles, ceria is redox-active and has shown potential for antioxidant therapies controlling ROS levels.…”
Section: Discussionmentioning
confidence: 99%
“…1,3,39,40 However, current knowledge is still unsystematic and restricted to particular aspects of nanoparticles' capability to induce toxic and pathological processes or to alter structure and function in different cell types. 41À43 Nevertheless, among nanoparticles, ceria is redox-active and has shown potential for antioxidant therapies controlling ROS levels.…”
Section: Discussionmentioning
confidence: 99%
“…Murine embryonic stem cell culture and in vitro cardiac differen tiation Murine (m) ES cell-line D3 (CRL-1934, American Type Culture Collection, Manassas, VA) was used and cultured as previously described [21] . Briefly, undifferentiated mESCs were cultured on an irradiation-inactivated monolayer of mouse embryonic fibroblast feeders in Dulbecco's modified Eagle's minimal essential medium (DMEM, Gibco BRL, Karlsruhe, Germany), supplemented with 15% fetal bovine serum (FBS, Gibco BRL, Karlsruhe, Germany), 0.1 mmol/L mercaptoethanol (Sigma-Aldrich, St Louis, MO), non-essential amino acids (stock solution diluted 1:100; Hyclone, Logan, UT) and 1000 U/mL of recombinant mouse leukemia inhibitory factor (LIF) (Chemicon, Hofheim, Germany).…”
Section: Methodsmentioning
confidence: 99%
“…Briefly, undifferentiated mESCs were cultured on an irradiation-inactivated monolayer of mouse embryonic fibroblast feeders in Dulbecco's modified Eagle's minimal essential medium (DMEM, Gibco BRL, Karlsruhe, Germany), supplemented with 15% fetal bovine serum (FBS, Gibco BRL, Karlsruhe, Germany), 0.1 mmol/L mercaptoethanol (Sigma-Aldrich, St Louis, MO), non-essential amino acids (stock solution diluted 1:100; Hyclone, Logan, UT) and 1000 U/mL of recombinant mouse leukemia inhibitory factor (LIF) (Chemicon, Hofheim, Germany). To induce cardiac differentiation, embryoid bodies (EBs) were generated from hanging drops of approximately 800 mESCs in 20 μl of culture medium in the absence of leukemia inhibitory factor and feeder cells for two days and then grown in suspension or five more days [21] . …”
Section: Methodsmentioning
confidence: 99%
“…The first application of SPIO in cardiovascular regenerative medicine therapies was to label exogenous stem cells in order track these cells after injection into the infarct region in rodent models of MI (Kraitchman et al, 2003). While several studies show that IONPs do not affect cell viability, phenotype or therapeutic potential (Au et al, 2009;Li et al, 2013), other studies have raised concerns on their safety (Mahmoudi et al, 2011(Mahmoudi et al, , 2012Ge et al, 2013). Furthermore, their ability to track transplanted cells by MRI is controversial as the uptake of IONP by resident macrophages in the advent of transplanted cell apoptosis results in false-positive signals of cell engraftment in the infarct (Amsalem et al, 2007).…”
Section: (Vlp Vaccine Formentioning
confidence: 99%